Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer

Presse/Média: Research

Périodefévr. 11 2020

Couverture média

11

Couverture média

  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaGlobal English (Middle East and North Africa Financial Network)
    Pays/TerritoireJordan
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaPR Newswire
    Pays/TerritoireUnited States
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaBioSpace
    Pays/TerritoireUnited States
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaIndia Pharma News
    Pays/TerritoireIndia
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaProfitQuotes.com
    Pays/TerritoireUnited States
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaTickerTech.com
    Pays/TerritoireUnited States
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaFinanzen.ch
    Pays/TerritoireSwitzerland
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaFirstWord Pharma
    Pays/TerritoireUnited States
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaHealthcare Sales & Marketing Network
    Pays/TerritoireUnited States
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaKOTV
    Pays/TerritoireUnited States
    Date2/11/20
    PersonnesRobert Joseph Abraham
  • TitreVividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
    Nom du médiaKPVI
    Pays/TerritoireUnited States
    Date2/11/20
    PersonnesRobert Joseph Abraham